Overall survival in 92,991 colorectal cancer patients in Germany: differences according to type of comorbidity

O Riedel, J Viebrock, U Haug - Acta Oncologica, 2023 - Taylor & Francis
Background Poorer survival in cancer patients with vs. without comorbidity has been
reported for various cancer sites. For patients with colorectal cancer (CRC), limited data are …

Post-colonoscopy colorectal cancers in a national fecal immunochemical test-based colorectal cancer screening program

PHA Wisse, SY de Boer, MO Pool, JST sive Droste… - …, 2024 - thieme-connect.com
Background Post-colonoscopy colorectal cancers (PCCRCs) decrease the effect of
colorectal cancer (CRC) screening programs. To enable PCCRC incidence reduction in the …

Misleading and avoidable: design-induced biases in observational studies evaluating cancer screening—the example of site-specific effectiveness of screening …

M Braitmaier, S Schwarz, V Didelez, U Haug - medRxiv, 2024 - medrxiv.org
Objective Observational studies evaluating the effectiveness of cancer screening are often
biased due to an inadequate design where I) the assessment of eligibility, II) the assignment …

Positionspapier der Stiftung LebensBlicke 2023

JF Riemann, D Hüppe, U Haug, T Rösch… - Z …, 2023 - thieme-connect.com
Das deutsche Darmkrebs-Screening ist derzeit auf einem guten Entwicklungsstand [2]. Seit
2002 besteht ein paralleles Angebot von Stuhltest und Screening-Koloskopie. Bereits im …